MLAB Valuation
Mesa Laboratories Inc
$
116.750
- Overview
- Forecast
- Valuation
MLAB Relative Valuation
MLAB's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, MLAB is overvalued; if below, it's undervalued.
Historical Valuation
No Data
Competitors Valuation Multiple
The average P/S ratio for MLAB's competitors is 4.81, providing a benchmark for relative valuation. Mesa Laboratories Inc Corp (MLAB) exhibits a P/S ratio of 2.67, which is -44.45% above the industry average. Given its robust revenue growth of 17.52%, this premium appears unsustainable.
People Also Watch
CBLL
CeriBell Inc
18.060
USD
+1.29%
XPOF
Xponential Fitness Inc
8.790
USD
-1.12%
ARKO
Arko Corp.
4.995
USD
+0.50%
CFB
CrossFirst Bankshares Inc
15.990
USD
+0.13%
NBBK
NB Bancorp Inc
17.530
USD
-0.28%
PLYM
Plymouth Industrial REIT Inc
16.410
USD
-0.30%
GSL
Global Ship Lease Inc
25.840
USD
-2.05%
FCBC
First Community Bankshares Inc
39.505
USD
-0.11%
SCWX
SecureWorks Corp
8.510
USD
0.00%
BFST
Business First Bancshares Inc
24.580
USD
+0.20%
FAQ
Is Mesa Laboratories Inc (MLAB) currently overvalued or undervalued?
Mesa Laboratories Inc (MLAB) is now in the Undervalued zone, suggesting that its current forward PE ratio of 16.63 is considered Undervalued compared with the five-year average of 31.86. The fair price of Mesa Laboratories Inc (MLAB) is between 152.39 to 319.13 according to relative valuation methord. Compared to the current price of 116.75 USD , Mesa Laboratories Inc is Undervalued By 23.39% .
What is Mesa Laboratories Inc (MLAB) fair value?
How does MLAB's valuation metrics compare to the industry average?
What is the current P/B ratio for Mesa Laboratories Inc (MLAB) as of May 20 2025?
What is the current FCF Yield for Mesa Laboratories Inc (MLAB) as of May 20 2025?
What is the current Forward P/E ratio for Mesa Laboratories Inc (MLAB) as of May 20 2025?